Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Partridge

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Acta Oncologica (Stockholm, Sweden)|September 14, 2010
Imaging of normal lung, liver and parotid gland function for radiotherapyMike Partridge, Tokihiro Yamamoto, Cai Grau, et al.
Zeitschrift Fur Medizinische Physik|August 25, 2004
[Validation of a scatter correction method for IMRT verification using portal imaging]Ina Kyas, Mike Partridge, Bernd-Michael Hesse, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 14, 2007
Optimization of energy-window settings for scatter correction in quantitative (111)In imaging: comparison of measurements and Monte Carlo simulationsMaria Holstensson, Cecilia Hindorf, Michael Ljungberg, et al.
Radiation Oncology (London, England)|December 24, 2014
Comparison of Acuros (AXB) and Anisotropic Analytical Algorithm (AAA) for dose calculation in treatment of oesophageal cancer: effects on modelling tumour control probabilitySriram Padmanaban, Samantha Warren, Anthony Walsh, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2017
Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal CancerSamantha Warren, Christopher N Hurt, Thomas Crosby, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2010
A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicitySarah L Gulliford, Mike Partridge, Matthew R Sydes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 11, 2017
Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram dataDaniel L P Holyoake, Marianne Aznar, Somnath Mukherjee, et al.
Physics in Medicine and Biology|November 3, 2007
Characterization of the ultrasonic attenuation coefficient and its frequency dependence in a polymer gel dosimeterRemo A Crescenti, Jeffrey C Bamber, Mike Partridge, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2014
Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancerSamantha Warren, Mike Partridge, Rhys Carrington, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 17, 2009
Improvement in tumour control probability with active breathing control and dose escalation: a modelling studyMike Partridge, Alison Tree, Juliet Brock, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Acta Oncologica (Stockholm, Sweden)|September 14, 2010
Imaging of normal lung, liver and parotid gland function for radiotherapyMike Partridge, Tokihiro Yamamoto, Cai Grau, et al.
Zeitschrift Fur Medizinische Physik|August 25, 2004
[Validation of a scatter correction method for IMRT verification using portal imaging]Ina Kyas, Mike Partridge, Bernd-Michael Hesse, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 14, 2007
Optimization of energy-window settings for scatter correction in quantitative (111)In imaging: comparison of measurements and Monte Carlo simulationsMaria Holstensson, Cecilia Hindorf, Michael Ljungberg, et al.
Radiation Oncology (London, England)|December 24, 2014
Comparison of Acuros (AXB) and Anisotropic Analytical Algorithm (AAA) for dose calculation in treatment of oesophageal cancer: effects on modelling tumour control probabilitySriram Padmanaban, Samantha Warren, Anthony Walsh, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2017
Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal CancerSamantha Warren, Christopher N Hurt, Thomas Crosby, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2010
A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicitySarah L Gulliford, Mike Partridge, Matthew R Sydes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 11, 2017
Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram dataDaniel L P Holyoake, Marianne Aznar, Somnath Mukherjee, et al.
Physics in Medicine and Biology|November 3, 2007
Characterization of the ultrasonic attenuation coefficient and its frequency dependence in a polymer gel dosimeterRemo A Crescenti, Jeffrey C Bamber, Mike Partridge, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2014
Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancerSamantha Warren, Mike Partridge, Rhys Carrington, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 17, 2009
Improvement in tumour control probability with active breathing control and dose escalation: a modelling studyMike Partridge, Alison Tree, Juliet Brock, et al.
Pageof 6